Mariner Wealth Advisors (NYC)’s AstraZeneca AZN Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$103K	Buy	+1,512	New	+$105K	0.05%	100

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s AZN Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in AstraZeneca (AZN) in Q1 2015: 1,512 shares worth $103K. The stake represents 0.05% of the portfolio and ranks #100 among its holdings.

386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

Mariner Wealth Advisors (NYC) held 1,512 shares of AstraZeneca worth $103K as of Q1 2015.
AstraZeneca was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
AstraZeneca made up 0.05% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #100 holding.
386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.